Brokers Offer Predictions for HRTX Q1 Earnings
Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Equities researchers at Northland Capmk issued their Q1 2025 earnings estimates for Heron Therapeutics in a research note issued to investors on Thursday, February 27th. Northland Capmk analyst C. Byrnes anticipates that the biotechnology company will earn ($0.01) per share for the quarter. The consensus estimate for […]
Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Equities researchers at Northland Capmk issued their Q1 2025 earnings estimates for Heron Therapeutics in a research note issued to investors on Thursday, February 27th. Northland Capmk analyst C. Byrnes anticipates that the biotechnology company will earn ($0.01) per share for the quarter. The consensus estimate for […]
